Nanotechnology Based Drug Delivery System Of Rivastigmine For The Treatment Of Alzheimer’s Disease. Journal of Pharmaceutical Negative Results 2022, 2532-2541. https://doi.org/10.47750/pnr.2022.13.S01.298.